1 Introduction to Research & Analysis Reports 1.1 Adrenoleukodystrophy Drugs Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Adrenoleukodystrophy Drugs Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Adrenoleukodystrophy Drugs Overall Market Size 2.1 China Adrenoleukodystrophy Drugs Market Size: 2021 VS 2027 2.2 China Adrenoleukodystrophy Drugs Revenue, Prospects & Forecasts: 2016-2027 2.3 China Adrenoleukodystrophy Drugs Sales: 2016-2027 3 Company Landscape 3.1 Top Adrenoleukodystrophy Drugs Players in China Market 3.2 Top China Adrenoleukodystrophy Drugs Companies Ranked by Revenue 3.3 China Adrenoleukodystrophy Drugs Revenue by Companies 3.4 China Adrenoleukodystrophy Drugs Sales by Companies 3.5 China Adrenoleukodystrophy Drugs Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Adrenoleukodystrophy Drugs Companies in China Market, by Revenue in 2020 3.7 Manufacturers Adrenoleukodystrophy Drugs Product Type 3.8 Tier 1, Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Players in China Market 3.8.1 List of Tier 1 Adrenoleukodystrophy Drugs Companies in China 3.8.2 List of Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Adrenoleukodystrophy Drugs Market Size Markets, 2021 & 2027 4.1.2 Hormone Replacement 4.1.3 Transplant 4.1.4 Others 4.2 By Type - China Adrenoleukodystrophy Drugs Revenue & Forecasts 4.2.1 By Type - China Adrenoleukodystrophy Drugs Revenue, 2016-2021 4.2.2 By Type - China Adrenoleukodystrophy Drugs Revenue, 2022-2027 4.2.3 By Type - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027 4.3 By Type - China Adrenoleukodystrophy Drugs Sales & Forecasts 4.3.1 By Type - China Adrenoleukodystrophy Drugs Sales, 2016-2021 4.3.2 By Type - China Adrenoleukodystrophy Drugs Sales, 2022-2027 4.3.3 By Type - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027 4.4 By Type - China Adrenoleukodystrophy Drugs Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Adrenoleukodystrophy Drugs Market Size, 2021 & 2027 5.1.2 Childhood Cerebral ALD 5.1.3 Adrenomyeloneuropathy (AMN) 5.1.4 Addison-only 5.1.5 Others 5.2 By Application - China Adrenoleukodystrophy Drugs Revenue & Forecasts 5.2.1 By Application - China Adrenoleukodystrophy Drugs Revenue, 2016-2021 5.2.2 By Application - China Adrenoleukodystrophy Drugs Revenue, 2022-2027 5.2.3 By Application - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027 5.3 By Application - China Adrenoleukodystrophy Drugs Sales & Forecasts 5.3.1 By Application - China Adrenoleukodystrophy Drugs Sales, 2016-2021 5.3.2 By Application - China Adrenoleukodystrophy Drugs Sales, 2022-2027 5.3.3 By Application - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027 5.4 By Application - China Adrenoleukodystrophy Drugs Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Bluebird Bio Inc 6.1.1 Bluebird Bio Inc Corporation Information 6.1.2 Bluebird Bio Inc Overview 6.1.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021) 6.1.4 Bluebird Bio Inc Adrenoleukodystrophy Drugs Product Description 6.1.5 Bluebird Bio Inc Recent Developments 6.2 NeuroVia, Inc. 6.2.1 NeuroVia, Inc. Corporation Information 6.2.2 NeuroVia, Inc. Overview 6.2.3 NeuroVia, Inc. Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021) 6.2.4 NeuroVia, Inc. Adrenoleukodystrophy Drugs Product Description 6.2.5 NeuroVia, Inc. Recent Developments 6.3 Orpheris, Inc. 6.3.1 Orpheris, Inc. Corporation Information 6.3.2 Orpheris, Inc. Overview 6.3.3 Orpheris, Inc. Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021) 6.3.4 Orpheris, Inc. Adrenoleukodystrophy Drugs Product Description 6.3.5 Orpheris, Inc. Recent Developments 6.4 Minoryx 6.4.1 Minoryx Corporation Information 6.4.2 Minoryx Overview 6.4.3 Minoryx Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021) 6.4.4 Minoryx Adrenoleukodystrophy Drugs Product Description 6.4.5 Minoryx Recent Developments 6.5 MedDay Pharmaceuticals 6.5.1 MedDay Pharmaceuticals Corporation Information 6.5.2 MedDay Pharmaceuticals Overview 6.5.3 MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021) 6.5.4 MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Product Description 6.5.5 MedDay Pharmaceuticals Recent Developments 7 China Adrenoleukodystrophy Drugs Production Capacity, Analysis 7.1 China Adrenoleukodystrophy Drugs Production Capacity, 2016-2027 7.2 Adrenoleukodystrophy Drugs Production Capacity of Key Manufacturers in China Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Adrenoleukodystrophy Drugs Supply Chain Analysis 9.1 Adrenoleukodystrophy Drugs Industry Value Chain 9.2 Adrenoleukodystrophy Drugs Upstream Market 9.3 Adrenoleukodystrophy Drugs Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Adrenoleukodystrophy Drugs Distributors and Sales Agents in China Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Adrenoleukodystrophy Drugs in China Market Table 2. Top Adrenoleukodystrophy Drugs Players in China Market, Ranking by Revenue (2019) Table 3. China Adrenoleukodystrophy Drugs Revenue by Companies, (US$, Mn), 2016-2021 Table 4. China Adrenoleukodystrophy Drugs Revenue Share by Companies, 2016-2021 Table 5. China Adrenoleukodystrophy Drugs Sales by Companies, (K Units), 2016-2021 Table 6. China Adrenoleukodystrophy Drugs Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Adrenoleukodystrophy Drugs Price (2016-2021) & (US$/Unit) Table 8. Manufacturers Adrenoleukodystrophy Drugs Product Type Table 9. List of Tier 1 Adrenoleukodystrophy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Hormone Replacement Table 12. Major Manufacturers of Transplant Table 13. By Type – China Adrenoleukodystrophy Drugs Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2016-2021 Table 15. By Type - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2022-2027 Table 16. By Type - China Adrenoleukodystrophy Drugs Sales (K Units), 2016-2021 Table 17. By Type - China Adrenoleukodystrophy Drugs Sales (K Units), 2022-2027 Table 18. By Application – China Adrenoleukodystrophy Drugs Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2016-2021 Table 20. By Application - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2022-2027 Table 21. By Application - China Adrenoleukodystrophy Drugs Sales (K Units), 2016-2021 Table 22. By Application - China Adrenoleukodystrophy Drugs Sales (K Units), 2022-2027 Table 23. Bluebird Bio Inc Corporation Information Table 24. Bluebird Bio Inc Description and Major Businesses Table 25. Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 26. Bluebird Bio Inc Adrenoleukodystrophy Drugs Product Table 27. Bluebird Bio Inc Recent Developments Table 28. NeuroVia, Inc. Corporation Information Table 29. NeuroVia, Inc. Description and Major Businesses Table 30. NeuroVia, Inc. Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 31. NeuroVia, Inc. Adrenoleukodystrophy Drugs Product Table 32. NeuroVia, Inc. Recent Developments Table 33. Orpheris, Inc. Corporation Information Table 34. Orpheris, Inc. Description and Major Businesses Table 35. Orpheris, Inc. Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 36. Orpheris, Inc. Adrenoleukodystrophy Drugs Product Table 37. Orpheris, Inc. Recent Developments Table 38. Minoryx Corporation Information Table 39. Minoryx Description and Major Businesses Table 40. Minoryx Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 41. Minoryx Adrenoleukodystrophy Drugs Product Table 42. Minoryx Recent Developments Table 43. MedDay Pharmaceuticals Corporation Information Table 44. MedDay Pharmaceuticals Description and Major Businesses Table 45. MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 46. MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Product Table 47. MedDay Pharmaceuticals Recent Developments Table 48. Adrenoleukodystrophy Drugs Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units) Table 49. China Adrenoleukodystrophy Drugs Capacity Market Share of Key Manufacturers, 2019-2021 Table 50. Adrenoleukodystrophy Drugs Market Opportunities & Trends in China Market Table 51. Adrenoleukodystrophy Drugs Market Drivers in China Market Table 52. Adrenoleukodystrophy Drugs Market Restraints in China Market Table 53. Adrenoleukodystrophy Drugs Raw Materials Table 54. Adrenoleukodystrophy Drugs Raw Materials Suppliers in China Market Table 55. Typical Adrenoleukodystrophy Drugs Downstream Table 56. Adrenoleukodystrophy Drugs Downstream Clients in China Market Table 57. Adrenoleukodystrophy Drugs Distributors and Sales Agents in China Market List of Figures Figure 1. Adrenoleukodystrophy Drugs Product Picture Figure 2. Adrenoleukodystrophy Drugs Segment by Type Figure 3. Adrenoleukodystrophy Drugs Segment by Application Figure 4. China Adrenoleukodystrophy Drugs Market Overview: 2020 Figure 5. China Adrenoleukodystrophy Drugs Market Size: 2021 VS 2027 (US$, Mn) Figure 6. China Adrenoleukodystrophy Drugs Revenue, 2016-2027 (US$, Mn) Figure 7. Adrenoleukodystrophy Drugs Sales in China Market: 2016-2027 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Adrenoleukodystrophy Drugs Revenue in 2020 Figure 9. Hormone Replacement Product Picture Figure 10. Transplant Product Picture Figure 11. Others Product Picture Figure 12. By Type - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027 Figure 13. By Type - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027 Figure 14. By Type - China Adrenoleukodystrophy Drugs Price (US$/Unit), 2016-2027 Figure 15. Childhood Cerebral ALD Figure 16. Adrenomyeloneuropathy (AMN) Figure 17. Addison-only Figure 18. Others Figure 19. By Application - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027 Figure 20. By Application - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027 Figure 21. By Application - China Adrenoleukodystrophy Drugs Price (US$/Unit), 2016-2027 Figure 22. Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. NeuroVia, Inc. Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Orpheris, Inc. Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Minoryx Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. China Adrenoleukodystrophy Drugs Production Capacity (K Units), 2016-2027 Figure 28. Adrenoleukodystrophy Drugs Industry Value Chain Figure 29. Marketing Channels

Bluebird Bio Inc NeuroVia, Inc. Orpheris, Inc. Minoryx MedDay Pharmaceuticals